Drugs Flashcards
Triptans (Sumatriptan etc)
Used to treat migraines
They are selective 5HT1B/5HT1D agonists
5HT1B receptors are on smooth muscle and voasconstriction
5HT1D lies on trigeminal nerve terminals and blocks release of vasoactive peptides from trigeminal nerves
What drugs are used in the prophylaxis of migraine?
B-blockers (bisoprolol, propanolol etc)
Antiepileptic drugs (gabapentin, pregabalin etc)
Antidepressants (Amitriptyline etc)
Calcium channel blockers (Nifidipine etc)
Tissue plasminogen activator (tPA)
Used to treat ischaemic stroke only
Disperses thrombus and restores blood flow
Must be administered in 3 hours for maximum effect
Stroke prophylaxis
Antihypertensives
Statins (reduces risk of thrombus formation but also contraindicated in haemorrhagic stroke)
Antiplatelets (Aspirin, clopidogrel)
Anticoahulants (Warfarin)
Compression stockings
Orlistat
Only centrally acting licensed drug in the UK for obesity
Acts as a lipase inhibitor and prevents the breakdown of dietary fats to fatty acids as well as decreasing the absorption of fats by 30%
Side effects of orlistat
Oily stools, abdominal cramps, flatus with discharge
Anti epileptics (VGSC blockers)
Phenytoin, Carbamazepine, Lamotrigine, Sodium Valproate
Keeps the VGSC in an inactivated state allowing it to produce 1 AP but not many successive AP’s
Anti-epileptics (VGCC blockers)
Ethosuxamide, Gabapentin, phenytoin
Allows for AP causes by VGSC but does not allow it to be propagated by VGCC’s
Levetiracetam
Anti epileptic that directly reduces vesicle fusion hence there is less Glu release therefore less neuronal excitation
Vigabatrin
Anti-epileptic that increase GABA synthesis causing more inhibition of neurones
Tigabine
Anti-epileptic that reduces the reuptake of GABA allowing for inhibition of neurones
How do benzodiazepines and barbituates help with epilepsy?
They increase the effectiveness of GABAa receptors which are Cl- channels which will prolong channel open time
Felbamate
Anti-epileptic that blocks NMDAr’s thereby reducing AP’s
However very hepatotoxic
Topiramate
Anti-epileptic that blocks AMPA/Kainate receptors thereby reducing AP’s
Retigabine
Anti-epileptic that activates K+ channels and makes the neurone less excitable both pre/post synaptically
Lesigamane
Anti-epileptic that blocks low threshold Na currents which decreases the propagation of AP’s
L-DOPA
Aimed at replacing the lost DA in Parkinson’s
L-DOPA is converted to DA by DOPA decarboxylase thereby causing increased DA synthesis
Carbidopa/bensarzide
Co-administered with L-DOPA to as a peripheral DA blocker to reduce the peripheral side effects of L-DOPA